AGR2 and hepatocellular carcinoma: This is the first report to uncover the molecular mechanism involved in sorafenib resistance, and further elucidation of the predictive role and molecular and cellular mechanisms of AGR2 related to sorafenib resistance may provide additional opportunities to establish complementary therapies for HCC.